Revealing Role of Epigenetic Modifiers and DNA Oxidation in Cell-Autonomous Regulation of Cancer Stem Cells

Researchers used pharmacological inhibitor of H3K4, knockdown of KMT2B or KMT2D in breast cancer cells, real time PCR, response to chemotherapy, flow cytometry, and more for circulating markers of CSCs and DNA hydroxylases in breast cancer patients.